Nishida T - Search Results

1

Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.

Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T. Takenaka K, et al. Among authors: nishida t. Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26. Biol Blood Marrow Transplant. 2015. PMID: 26211985 Free article.

2

Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens.

Akatsuka Y, Nishida T, Kondo E, Miyazaki M, Taji H, Iida H, Tsujimura K, Yazaki M, Naoe T, Morishima Y, Kodera Y, Kuzushima K, Takahashi T. Akatsuka Y, et al. Among authors: nishida t. J Exp Med. 2003 Jun 2;197(11):1489-500. doi: 10.1084/jem.20021925. Epub 2003 May 27. J Exp Med. 2003. PMID: 12771180 Free PMC article.

3

Potential limitations in using minor histocompatibility antigen-specific cytotoxic T cells for targeting solid tumor cells.

Miyazaki M, Akatsuka Y, Nishida T, Fujii N, Hiraki A, Ikeda K, Tsujimura K, Kuzushima K, Morishima Y, Sato S, Ueda R, Takahashi T. Miyazaki M, et al. Among authors: nishida t. Clin Immunol. 2003 Jun;107(3):198-201. doi: 10.1016/s1521-6616(03)00065-2. Clin Immunol. 2003. PMID: 12804533

4

Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant.

Nishida T, Akatsuka Y, Morishima Y, Hamajima N, Tsujimura K, Kuzushima K, Kodera Y, Takahashi T. Nishida T, et al. Br J Haematol. 2004 Mar;124(5):629-35. doi: 10.1111/j.1365-2141.2004.04823.x. Br J Haematol. 2004. PMID: 14871250 Free article.

5

A UGT2B17-positive donor is a risk factor for higher transplant-related mortality and lower survival after bone marrow transplantation.

Terakura S, Murata M, Nishida T, Emi N, Akatsuka Y, Riddell SR, Morishima Y, Kodera Y, Naoe T. Terakura S, et al. Among authors: nishida t. Br J Haematol. 2005 Apr;129(2):221-8. doi: 10.1111/j.1365-2141.2005.05427.x. Br J Haematol. 2005. PMID: 15813850 Free article.

6

Human leukocyte antigen haploidentical hematopoietic stem cell transplantation: indications and tentative outcomes in Japan.

Kodera Y, Nishida T, Ichinohe T, Saji H. Kodera Y, et al. Among authors: nishida t. Semin Hematol. 2005 Apr;42(2):112-8. doi: 10.1053/j.seminhematol.2005.02.001. Semin Hematol. 2005. PMID: 15846577 Review.

7

Adoptive transfer of allogeneic antigen-specific T cells.

Riddell SR, Bleakley M, Nishida T, Berger C, Warren EH. Riddell SR, et al. Among authors: nishida t. Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 1):9-12. doi: 10.1016/j.bbmt.2005.10.025. Biol Blood Marrow Transplant. 2006. PMID: 16399578 Free article. Review.

8

High titer of ADAMTS13 inhibitor associated with thrombotic microangiopathy of the gut and skeletal muscle after allogeneic hematopoietic stem cell transplantation.

Adachi T, Matsushita T, Ichihashi R, Hirashima K, Ito M, Inukai A, Yokozawa T, Nishida T, Murata M, Hayashi M, Katsumi A, Kojima T, Saito H, Naoe T. Adachi T, et al. Among authors: nishida t. Int J Hematol. 2006 Jun;83(5):415-9. doi: 10.1532/IJH97.05157. Int J Hematol. 2006. PMID: 16787872

9

Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients.

Nishida T, Murayama T, Hirai H, Okamoto S, Sao H, Hara M, Kanamori H, Atsuta Y, Matsuo K, Morishima Y, Kodera Y. Nishida T, et al. Int J Hematol. 2009 Jan;89(1):98-105. doi: 10.1007/s12185-008-0219-8. Epub 2008 Dec 4. Int J Hematol. 2009. PMID: 19052693 Clinical Trial.

10

Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy.

Nishiwaki S, Nakayama T, Murata M, Nishida T, Sugimoto K, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Goto T, Koyama D, Yokohata E, Kubota N, Kamoshita S, Miyamura K, Matsumoto K, Ito M, Naoe T. Nishiwaki S, et al. Among authors: nishida t. Int J Hematol. 2012 Apr;95(4):428-33. doi: 10.1007/s12185-012-1023-z. Epub 2012 Feb 15. Int J Hematol. 2012. PMID: 22351164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,853 results

Search Page

Filters